Every news release from Resverlogix this year contains the sentence "Resverlogix is planning to study RVX-208 in a proposed Phase 3 clinical trial." That is where my skepticim stems from. Maybe they have to say that because the trial hasn't been announced yet. I just hope it doesn't mean that they are struggling to get the FDA/EMA to allow them to go straight to Phase 3 w/o doing another Phase 2.